The Ectodermal Dysplasias-Burden of Disease Score: Development and Validation of an Ectodermal Dysplasia Family/Parental Burden Score
DOI:
https://doi.org/10.2340/actadv.v103.5203Keywords:
Ectodermal dysplasias, Genodermatoses, Quality of life, Parents, Burden of diseases, QuestionnaireAbstract
Ectodermal dysplasias are genetic conditions affecting the development and/or homeostasis of 2 or more ectodermal derivatives, including hair, teeth, nails, and certain glands. No tool is available to assess the burden of ectodermal dysplasias and its multidimensional impact on patients and their families. This study developed and validated a familial/parental 19-item burden questionnaire designed specifically for ectodermal dysplasias. Each group of questions was linked to 1 of the following dimensions: (i) Impact of the disease on social life and hobbies; (ii) Future prospects; (iii) Restraint of the disease on outdoor activities; (iv) Financial burden of the disease; (v) Acceptance of the disease. Cronbach’s alpha was 0.91 for the entire Ectodermal Dysplasias-Burden of Disease (ED-BD) scale, confirming excellent internal coherence. Intradimensional coherences all demonstrated excellent reliability (α > 0.76). The ED-BD questionnaire was highly correlated with the Short Form-12 and Psychological General Well Being Index validated questionnaires. Cultural and linguistic validation in US English was conducted. Development and validation of the questionnaire was based on data from patients with the 2 main ectodermal dysplasias subtypes. This ED-BD questionnaire represents the first specific assessment tool for evaluating the familial/parental burden of ectodermal dysplasias.
Downloads
References
Peschel N, Wright JT, Koster MI, Clarke AJ, Tadini G, Fete M, et al. Molecular pathway-based classification of ectodermal dysplasias: first five-yearly update. Genes (Basel) 2022; 13: 2327.
https://doi.org/10.3390/genes13122327 DOI: https://doi.org/10.3390/genes13122327
Wohlfart S, Meiller R, Hammersen J, Park J, Menzel-Severing J, Melichar VO, et al. Natural history of X-linked hypohidrotic ectodermal dysplasia: a 5-year follow-up study. Orphanet J Rare Dis 2020; 15: 7.
https://doi.org/10.1186/s13023-019-1288-x DOI: https://doi.org/10.1186/s13023-019-1288-x
Maillard A, Alby C, Gabison E, Doan S, Caux F, Bodemer C, et al. P63-related disorders: Dermatological characteristics in 22 patients. Exp Dermatol 2019; 28: 1190-1195.
https://doi.org/10.1111/exd.14045 DOI: https://doi.org/10.1111/exd.14045
Trzeciak WH, Koczorowski R. Molecular basis of hypohidrotic ectodermal dysplasia: an update. J Appl Genet 2016; 57: 51-61.
https://doi.org/10.1007/s13353-015-0307-4 DOI: https://doi.org/10.1007/s13353-015-0307-4
Saltnes SS, Jensen JL, Sæves R, Nordgarden H, Geirdal AØ. Associations between ectodermal dysplasia, psychological distress and quality of life in a group of adults with oligodontia. Acta Odontol Scand 2017; 75: 564-572.
https://doi.org/10.1080/00016357.2017.1357189 DOI: https://doi.org/10.1080/00016357.2017.1357189
Pavlis MB, Rice ZP, Veledar E Bradley BR, Spraker MK, Chen SC. Quality of life of cutaneous disease in the ectodermal dysplasias. Pediatr Dermatol 2010; 27: 260-265.
https://doi.org/10.1111/j.1525-1470.2010.01121.x DOI: https://doi.org/10.1111/j.1525-1470.2010.01121.x
WHO | About the Global Burden of Disease (GBD) project. WHO. [Accessed March 6, 2020] Available from https://www.who.int/healthinfo/global_burden_disease/about/en/.
Chren MM, Weinstock MA. Conceptual issues in measuring the burden of skin diseases. J Investig Dermatol Symp Proc 2004; 9: 97-100.
https://doi.org/10.1111/j.1087-0024.2004.09119.x DOI: https://doi.org/10.1111/j.1087-0024.2004.09119.x
Dufresne H, Hadj-Rabia S, Taieb C, Bodemer C. Development and validation of an epidermolysis bullosa family/parental burden score. Br J Dermatol 2015; 173: 1405-1410.
https://doi.org/10.1111/bjd.14072 DOI: https://doi.org/10.1111/bjd.14072
Dufresne H, Hadj-Rabia S, Méni C, Sibaud V, Bodemer C, Taïeb C. Family burden in inherited ichthyosis: creation of a specific questionnaire. Orphanet J Rare Dis 2013; 8: 28.
https://doi.org/10.1186/1750-1172-8-28 DOI: https://doi.org/10.1186/1750-1172-8-28
Morice-Picard F, Taïeb C, Marti A, Gliksohn A, Bennani M, Bodemer C, et al. Burden of albinism: development and validation of a burden assessment tool. Orphanet J Rare Dis 2018; 13: 162.
https://doi.org/10.1186/s13023-018-0894-3 DOI: https://doi.org/10.1186/s13023-018-0894-3
Taieb C, Hadj-Rabia S, Monnet J, Bennani M, Bodemer C. Incontinentia pigmenti burden scale: designing a family burden questionnaire. Orphanet J Rare Dis 2019; 14: 271.
https://doi.org/10.1186/s13023-019-1234-y DOI: https://doi.org/10.1186/s13023-019-1234-y
Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A. Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol 1994; 16: 93-104.
https://doi.org/10.1080/01688639408402620 DOI: https://doi.org/10.1080/01688639408402620
Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999; 2: 113-127.
https://doi.org/10.1046/j.1524-4733.1999.02210.x DOI: https://doi.org/10.1046/j.1524-4733.1999.02210.x
Ezzedine K, Bennani M, Shourick J, Taieb C. A Method for Designing a Patient Burden Questionnaire in Dermatology. Clin Cosmet Investig Dermatol 2020; 13: 521-528
https://doi.org/10.2147/CCID.S260323 DOI: https://doi.org/10.2147/CCID.S260323
Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res 2018; 27: 1171-1179.
https://doi.org/10.1007/s11136-017-1765-4 DOI: https://doi.org/10.1007/s11136-017-1765-4
Cronbach LJ, Warrington WG. Time-limit tests: Estimating their reliability and degree of speeding. Psychometrika 1951; 16: 167-188.
https://doi.org/10.1007/BF02289113 DOI: https://doi.org/10.1007/BF02289113
Bentler PM. Comparative fit indexes in structural models. Psychol Bull 1990; 107: 238-246.
https://doi.org/10.1037/0033-2909.107.2.238 DOI: https://doi.org/10.1037/0033-2909.107.2.238
Lim LL, Fisher JD. Use of the 12-item short-form (SF-12) Health Survey in an Australian heart and stroke population. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 1999; 8: 1-8.
https://doi.org/10.1023/A:1026409226544 DOI: https://doi.org/10.1023/A:1026409226544
Lundberg L, Johannesson M, Isacson DG, Borgquist L. The relationship between health-state utilities and the SF-12 in a general population. Med Decis Making 1999; 19: 128-140.
https://doi.org/10.1177/0272989X9901900203 DOI: https://doi.org/10.1177/0272989X9901900203
Gaston JE, Vogl L. Psychometric properties of the General Well-Being Index. Qual Life Res 2005; 14: 71-75.
https://doi.org/10.1007/s11136-004-0793-z DOI: https://doi.org/10.1007/s11136-004-0793-z
Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials. Selecting quality-of-life measures. Control Clin Trials 1991; 12: 204S-216S.
https://doi.org/10.1016/S0197-2456(05)80024-8 DOI: https://doi.org/10.1016/S0197-2456(05)80024-8
Wenger NK, Mattson ME, Furberg CD, Elinson J. Assessment of quality of life in clinical trials of cardiovascular therapies. Am J Cardiol 1984; 54: 908-913.
https://doi.org/10.1016/S0002-9149(84)80232-5 DOI: https://doi.org/10.1016/S0002-9149(84)80232-5
Namjoshi MA, Buesching DP. A review of the health-related quality of life literature in bipolar disorder. Qual Life Res Int J Qual Life Asp Treat Care Rehabil 2001; 10: 105-115.
https://doi.org/10.1023/A:1016662018075 DOI: https://doi.org/10.1023/A:1016662018075
Lundgren-Nilsson Å, Jonsdottir IH, Ahlborg G, Tennant A. Construct validity of the Psychological General Well Being Index (PGWBI) in a sample of patients undergoing treatment for stress-related exhaustion: a Rasch analysis. Health Qual Life Outcomes 2013; 11: 2.
https://doi.org/10.1186/1477-7525-11-2 DOI: https://doi.org/10.1186/1477-7525-11-2
Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health J Int Soc Pharmacoeconomics Outcomes Res 2005; 8: 94-104.
https://doi.org/10.1111/j.1524-4733.2005.04054.x DOI: https://doi.org/10.1111/j.1524-4733.2005.04054.x
Sampogna F, Finlay AY, Salek SS, Chernyshov P, Dalgard FJ, Evers AWM, et al. Measuring the impact of dermatological conditions on family and caregivers: a review of dermatology-specific instruments. J Eur Acad Dermatol Venereol 2017; 31: 1429-1439.
https://doi.org/10.1111/jdv.14288 DOI: https://doi.org/10.1111/jdv.14288
Rees J, O'Boyle C, MacDonagh R. Quality of life: impact of chronic illness on the partner. J R Soc Med 2001; 94: 563-566.
https://doi.org/10.1177/014107680109401103 DOI: https://doi.org/10.1177/014107680109401103
Basra MKA, Sue-Ho R, Finlay AY. The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 2007; 156: 528-538.
https://doi.org/10.1111/j.1365-2133.2006.07617.x DOI: https://doi.org/10.1111/j.1365-2133.2006.07617.x
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Helene Dufresne, Oriane Maincent, Charles Taieb, Christine Bodemer, Smail Hadj-Rabia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
